Organisations can apply for up to £500,000 (NET cost, excl. VAT) per project across all types of innovations, including but not limited to, medical devices, in vitro diagnostics, digital health solutions, software, artificial intelligence, services or new models of care.
Award: £500,000 per project
Opens: 10th Jul 2023
Closes: 11th Aug 2023
Living with autism and a learning disability can be difficult for patients and their families due to significant health inequalities these communities face, including lack of access to sufficient support and care, which are well documented not just in the UK but globally. Despite attempts to tackle these challenges across a range of settings and services, the pressures on healthcare systems continue to grow due to multiple factors.
Funded by NHS England through the Accelerated Access Collaborative, and in collaboration with Autistica and the AHSN Network, SBRI Healthcare was pleased to announce the opening of Competition 20 in May 2022 for funding innovations to support care in Autism and Learning Disabilities.
Only those projects that have completed Phase 1 successfully will be eligible to apply for Phase 2.
This competition seeks to address three primary issues, taking into account the systemic complexity and recognising some of the key influences on care delivery. The requirement is to find innovative solutions that will tackle challenges associated with:
1. Early identification and diagnosis
2. Health inequalities and access to care
3. Access to effective support and services
Applicants are asked to consider whether their innovation addresses any of the above challenges, the impact of their innovation on the whole system, and to be aware of the competitive environment, even considering working together with other companies and organisations to bring forward solutions that can make a real difference.
Applicants are further asked to consider the impact of their innovation in addressing and/or alleviating variations currently experienced in autism and learning disability care, for example through addressing inequality in access to care, intersectionality (e.g. related to cultural/ethnic minority groups), and geographic disparities.
This competition is open to all types of innovations, including but not limited to, medical devices, in vitro diagnostics, digital health solutions, software, artificial intelligence, services or new models of care.
Under the overall theme of “Autism and Learning Disabilities”, three categories have been identified via consultation with clinicians and other stakeholders working in provision of care across the spectrum. Applicants are expected to respond to one of the three categories and should consider if their solution is specific to or can be tailored to other categories, whilst being mindful of the broader impact on the autism and learning disabilities care system.
The competition is open to single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities and NHS Foundation Trusts, as long as a strong commercial strategy is provided. Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary. Collaborations are encouraged in the form of subcontracted services as appropriate.
Phase 2 contracts are intended to develop and evaluate prototypes or demonstration units
from the more promising technologies in Phase 1. Only those projects that have completed
Phase 1 successfully will be eligible for Phase 2. The number of available Phase 2 awards
is subject to budget availability.
Developments will be 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.
Phase 2 Competition Launch – 10 July 2023 9:00 am
Phase 2 Webinar – 18 July 2023
Deadline to Apply Phase 2 – 11 August 2023
Panel Phase 2 – 19 September 2023
Book an appointment to speak to one of our advisors to discuss your eligibility to apply for this Grant Funding opportunity.